Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is ...

Targeted alpha therapy shows promise in treating neuroendocrine tumours, offering hope where beta therapies fall short.

A review in Brain Medicine unveils the potential of targeted alpha particle therapy (TAT) as an innovative and exciting ...

It is one of the most aggressive forms of skin cancer, with current therapies—including immunotherapy and targeted drugs ... involves drugs labeled with alpha particle-emitting radioisotopes.

Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is ...

In a comprehensive Genomic Press Viewpoint (review) article, researchers are shining a spotlight on a revolutionary approach to tackling neuroendocrine tumors (NETs), a rare but increasingly prevalent ...

Researchers said alpha particles are promising therapies that target cancer while minimizing the damage to nearby healthy tissues.

MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated ...

Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers from Japan recently developed a new radioactive drug that ...

Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive drug that emits alpha ...